ara 290 peptide vs bpc 157 Healing Nerve Damage: ARA-290 and BPC-157 ARA-290 - CAS 1208243-50-8 -
Description
daily SQ at investigational doses
Data that remained non-normally distributed and/or heteroscedastic after log transformation were analyzed (not log-transformed, but still 1e13-transformed) with a KruskalWallis test, while normally distributed and homoscedastic data were analyzed with a one-way ANOVA, performed on the log-transformed data as necessary
In cases of long-standing or severe deficiency, nerve damage may be partially irreversible, highlighting the importance of early detection and treatment
He et al
